Chief Development Officer · Arbutus Biopharma Corp (ABUS)

Gaston Picchio

FY2018 is the first fiscal year CompBrief holds for Gaston Picchio as a named executive officer of Arbutus Biopharma; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2018

$1,495,000

Salary $87,000Stock awards $0

2nd of 3 named executive officers at Arbutus Biopharma by FY2018 total.

3 named officers on file for Arbutus Biopharma, FY2018

Gaston Picchio’s pay file — $29

  • 1 fiscal year of pay, line by line

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Arbutus Biopharma’s whole pay program stands against its peers

  • Arbutus Biopharma’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on ABUS→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 23, 2019 (DEF 14A).

Free

Get Gaston Picchio’s full pay file as a PDF — free

More than this page: up to 10 years of Gaston’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Gaston Picchio compensation by year

Arbutus Biopharma Summary Compensation Table · the one fiscal year held
In US dollars, as Arbutus Biopharma reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2018
Salary$87,000
Bonus$0
Stock awards$0
Option awards$1,376,000
Non-equity incentive$32,000
Pension and deferred compensation$0
All other$0
Total$1,495,000

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Arbutus Biopharma Corp DEF 14A filed April 23, 2019, accession 0001047469-19-002498, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Arbutus Biopharma Corp filed document, accession 0001047469-19-002498. Every figure is read from that document and cited to the page and table it appears in. Filed April 23, 2019.

Equity holdings

unvested awards at FY2018 year-end
TypeUnvested unitsValue at year-endExercise price
Option200,000—$9.38

Per the Outstanding Equity Awards at Fiscal Year-End table in Arbutus Biopharma Corp's FY2018 proxy; value at the fiscal year-end close, as the company printed it.

Arbutus Biopharma’s named executive officers, FY2018

as the company reported each
Named executive officerRoleFY2018 total
Mark MurrayPresident and Chief Executive Officer$2,527,885
Gaston Picchio · this pageChief Development Officer$1,495,000
David HastingsChief Financial Officer$1,452,867

The full Arbutus Biopharma compensation record

free company brief

This page is one person within Arbutus Biopharma's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Arbutus Biopharma's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Gaston Picchio's compensation dossier · One-time report. No refunds.